Market Overview

UPDATE: Teva Posts Upbeat Q1 Profit, Declares Dividend

Related TEVA
Teva Announces UK High Court Gives Positive Judgment In The Company's Patent Case Against AstraZeneca
Notable Hedge Funds Disclose Additions And Reductions To Holdings
Sofinnova Ventures Closes $500M Fund (Fox Business)

Teva Pharmaceutical Industries Limited (NASDAQ: TEVA) posted a rise in its first-quarter profit.

Its quarterly profit climbed to $859 million, or $0.97 per share, versus $761 million, or $0.84 per share, in the year-ago quarter. Excluding one-time items, Teva earned $1.47 per share, up from $1.04 per share. Its revenue climbed 25% to $5.1 billion.

Analysts were expecting earnings of $1.44 per share on revenue of $5.5 billion.

U.S. sales surged 46% to $2.8 billion. European sales fell 2% to $1.3 billion.

Teva also declared a quarterly cash dividend of 1 shekel (26.3 cents) per share.

Teva shares closed at $44.47 yesterday.

Posted-In: EarningsEarnings News

 

Related Articles (TEVA)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters